PT Review for Merck & Company, Inc. (NYSE:MRK)

Street analysts that cover Merck & Company, Inc. (NYSE:MRK), currently have a target price of $66.076 on company shares. 13 analysts are contributing to this target price which is the consensus number provided by Zacks Research. Each contributing analyst may have a different opinion on future stock movement. Covering analysts may look to previous resistance and support levels to assist in calculating a figure. The top target price estimate provided by analysts polled by Zacks Research is $80. The lowest target price prediction from these same analysts sits at $56. 

Zacks research also gives calculated recommendations from sell-side analysts that cover company shares. These recommendations land on a simplified scale provided by Zacks Research. Using data provided from various analysts, shares of Merck & Company, Inc. (NYSE:MRK) are presently listed with an ABR of 2. This number is using a recommendation scale where the ratings range from a 1 to a 5. Following this scale, a 1 would signify a Strong Buy while a 5 would represent a Strong Sell.

We can also take a look at some company earnings per share or EPS information. Earnings per share is the segment of profit for a company that is allocated to every outstanding share of a company’s common stock. Earnings per share numbers can serve as an indicator for the profitability of a certain company. EPS is broadly thought to be one of the most important factors when evaluating the price of a share. A Zacks consensus currently shows Street analysts projecting the company to post per share earnings of $0.98. For the period ending 2016-06-30, Merck & Company, Inc. (NYSE:MRK) reported actual EPS of $0.93. This number was $0.01 away from analyst predictions, providing a surprise factor of 1.09%. The company is expected to next release earnings on or around 2016-10-25.

The data in this report is in part provided by Zacks Research and Yahoo Finance.  The author does not have, nor plans to take any position in Merck & Company, Inc. shares within the next 14 days.  Readers should not consider this as a recommendation to buy or sell company stock.  This piece is for informational purposes only.  Potentialy investors should always conduct full research before making investment decisions. 

Leave a Comment